Gorlova OY - Search Results

1

GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example.

Gorlov IP, Gallick GE, Gorlova OY, Amos C, Logothetis CJ. Gorlov IP, et al. Among authors: gorlova oy. PLoS One. 2009 Aug 4;4(8):e6511. doi: 10.1371/journal.pone.0006511. PLoS One. 2009. PMID: 19652704 Free PMC article.

2

Cost-benefit analysis of recombination and its application for understanding of chiasma interference.

Gorlov IP, Gorlova OY. Gorlov IP, et al. Among authors: gorlova oy. J Theor Biol. 2001 Nov 7;213(1):1-8. doi: 10.1006/jtbi.2001.2397. J Theor Biol. 2001. PMID: 11708850

3

Power of a simplified multivariate test for genetic linkage.

Gorlova OY, Amos CI, Zhu DK, Wang W, Turner S, Boerwinkle E. Gorlova OY, et al. Ann Hum Genet. 2002 Nov;66(Pt 5-6):407-17. doi: 10.1017/S0003480002001239. Ann Hum Genet. 2002. PMID: 12485473

4

Genetic linkage and imprinting effects on body mass index in children and young adults.

Gorlova OY, Amos CI, Wang NW, Shete S, Turner ST, Boerwinkle E. Gorlova OY, et al. Eur J Hum Genet. 2003 Jun;11(6):425-32. doi: 10.1038/sj.ejhg.5200979. Eur J Hum Genet. 2003. PMID: 12774034

5

Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers.

Gorlov IP, Gorlova OY, Frazier ML, Amos CI. Gorlov IP, et al. Among authors: gorlova oy. Am J Hum Genet. 2003 Nov;73(5):1157-61. doi: 10.1086/378819. Epub 2003 Oct 1. Am J Hum Genet. 2003. PMID: 14526391 Free PMC article.

6

Genetic susceptibility for lung cancer: interactions with gender and smoking history and impact on early detection policies.

Gorlova OY, Amos C, Henschke C, Lei L, Spitz M, Wei Q, Wu X, Kimmel M. Gorlova OY, et al. Hum Hered. 2003;56(1-3):139-45. doi: 10.1159/000073742. Hum Hered. 2003. PMID: 14614248

7

Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).

Gorlov IP, Gorlova OY, Frazier ML, Amos CI. Gorlov IP, et al. Among authors: gorlova oy. Mutat Res. 2004 Oct 4;554(1-2):175-83. doi: 10.1016/j.mrfmmm.2004.04.014. Mutat Res. 2004. PMID: 15450416

8

Predicting the oncogenicity of missense mutations reported in the International Agency for Cancer Research (IARC) mutation database on p53.

Gorlov IP, Gorlova OY, Amos CI. Gorlov IP, et al. Among authors: gorlova oy. Hum Mutat. 2005 Nov;26(5):446-54. doi: 10.1002/humu.20242. Hum Mutat. 2005. PMID: 16173033

9

Never smokers and lung cancer risk: a case-control study of epidemiological factors.

Gorlova OY, Zhang Y, Schabath MB, Lei L, Zhang Q, Amos CI, Spitz MR. Gorlova OY, et al. Int J Cancer. 2006 Apr 1;118(7):1798-804. doi: 10.1002/ijc.21561. Int J Cancer. 2006. PMID: 16217766

10

Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk.

Wu X, Lin J, Etzel CJ, Dong Q, Gorlova OY, Zhang Q, Amos CI, Spitz MR. Wu X, et al. Among authors: gorlova oy. Int J Cancer. 2007 Jun 15;120(12):2687-95. doi: 10.1002/ijc.22588. Int J Cancer. 2007. PMID: 17290394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters